Form 8-K - Current report:
SEC Accession No. 0000950170-24-113524
Filing Date
2024-10-08
Accepted
2024-10-08 16:05:07
Documents
11
Period of Report
2024-10-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K sana-20241004.htm   iXBRL 8-K 53915
  Complete submission text file 0000950170-24-113524.txt   180621

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sana-20241004.xsd EX-101.SCH 31893
13 EXTRACTED XBRL INSTANCE DOCUMENT sana-20241004_htm.xml XML 4890
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 241360361
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)